Kekkan Biologics
A platform company developing first-in-class biologics against severe neovascular and fibrotic disorders.
Niveau de maturité
- Idéation
- R&D
- Minimum viable product
- 1er client / 1ers utilisateurs
- Commercialisation
L’histoire
A spin-off from the laboratory of Dr. Gilles PAGES, University of Nice Cote d’Azur (Université de Nice Côte d’Azur) and the Institute for Research on Cancer and Aging (IRCAN).
More than 20 years of internationally recognized cutting-edge research in cancer biology involving tumor angiogenesis and lymphangiogenesis.
A pipeline of antibodies against several validated targets in angiogenesis and lymphangiogenesis pathways.